NCT Etude Statut Mise à jour
NCT04183608 An Open-label Randomized Trial COmparing staNdard of Care Versus Treat to Target With telemonitoRing and Patient Education in Patients With Ulcerative cOlitis Initiating adaLimumab: The CONTROL Trial En recrutement 16 avril 2026
NCT04184635 Assessment of ECMO in Acute Myocardial Infarction With Non-reversible Cardiogenic Shock to Halt Organ Failure and Reduce Mortality (ANCHOR) En recrutement 27 décembre 2025
NCT04050956 French Cohort of Myocardial Infarction Evaluation En recrutement 27 décembre 2025
NCT02450396 Prospective Observational Study About Pregnancy and Medically Assisted Conception in Rare Diseases En recrutement 27 décembre 2025
NCT06497140 A Randomized Sham-controlled, Multicenter Trial on the Effect of Genicular Arteries Embolization in Symptomatic Knee Osteoarthritis En recrutement 27 décembre 2025
NCT06421012 Preoxygenation for Tracheal Aspirations in Intensive Care, a Randomized Controlled Trial En recrutement 27 décembre 2025
NCT05211401 Rituximab in Patients With ST-elevation Myocardial Infarction: A Phase 2 Placebo-controlled Randomized Clinical Trial: RITA-MI 2 En recrutement 27 décembre 2025
NCT05874505 "Multicenter, Randomized, Prospective Trial Comparing the Efficacy and Safety of Adalimumab to That of Tocilizumab in Severe Uveitis of Behçet's Disease" (UVB) : Treatment of UVeitis in Behçet's Diseases With Biologics En recrutement 27 décembre 2025
NCT05247554 Randomized Controlled Trial Testing the Effect of Hydroxychloroquine Combined With Low-dose Corticosteroid Therapy in Pulmonary Sarcoidosis En recrutement 27 décembre 2025
NCT05784051 Prophylactic Frequent Premature Ventricular complexeS sUPPression on Left ventriculaR Function impairmEnt in aSymptomatic patientS En recrutement 27 décembre 2025
NCT04763447 Impact of Omalizumab Withdrawal After a 3 Year Duration Treatment in Well Controlled Severe Allergic Asthma : a Multicentric Randomized Controlled Trial En recrutement 27 décembre 2025